Marta Ruiz

发表

Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor

J. Prieto, O. Rabal, J. Oyarzábal, 2017, Oncotarget.

PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity.

C. Wellbrock, I. Arozarena, K. Breckpot, 2017, Cell reports.

Identification and Characterization of a T-Helper Peptide from Carcinoembryonic Antigen

J. Prieto, J. Lasarte, E. Celis, 2004, Clinical Cancer Research.

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

Ibon Tamayo, S. Hervás-Stubbs, J. Lasarte, 2022, Frontiers in Immunology.

Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10

P. Sarobe, Diana Llópiz, Leyre Silva, 2018, Front. Immunol..

Peptide inhibitors of transforming growth factor‐β enhance the efficacy of antitumor immunotherapy

J. Prieto, P. Berraondo, J. Lasarte, 2009, International journal of cancer.

Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy.

J. Berzofsky, D. Stroncek, J. Lasarte, 2020, Cancer letters.

Epirubicin, cyclophosphamide and weekly paclitaxel as neoadjuvant chemotherapy for stage II and III breast cancer

M. Ruiz, Miguel González, D. A. Bujanda, 2006, Journal of Cancer Research and Clinical Oncology.

Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.

J. Prieto, B. Sangro, E. Huarte, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Lymphocytes from Carcinoembryonic Antigen Identification of an Antigenic Epitope for Helper T Updated Version

J. Prieto, B. Sangro, E. Huarte, 2002 .

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma

B. Sangro, J. Lasarte, A. Lujambio, 2020, Cancers.

The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

José L Carrascosa, Teresa Lozano, Pablo Sarobe, 2017, Oncoimmunology.

T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides.

J. Prieto, J. Lasarte, P. Sarobe, 1999, International immunology.

Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responses.

J. Prieto, J. Lasarte, P. Sarobe, 2003, International immunology.

Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation

J. Prieto, J. Oyarzábal, P. Coffer, 2015, The Journal of Immunology.

StimulationEnhances T Cell Function after TCR Inhibition of FOXP3/NFAT Interaction

J. Oyarzábal, P. Coffer, S. Hervás-Stubbs, 2015 .

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model

V. Trochon-Joseph, B. Sangro, J. Lasarte, 2018, Cancer Immunology, Immunotherapy.

Adjuvant combination and antigen targeting as a strategy to induce polyfunctional and high-avidity T-cell responses against poorly immunogenic tumors.

J. Prieto, J. Lasarte, J. Riezu-Boj, 2011, Cancer research.

IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination

S. Hervás-Stubbs, J. Lasarte, E. Guruceaga, 2016, Oncotarget.

Neoantigens as potential vaccines in hepatocellular carcinoma

L. Buonaguro, B. Sangro, S. Hervás-Stubbs, 2022, Journal for ImmunoTherapy of Cancer.

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination

Flor Navarro, S. Hervás-Stubbs, J. Lasarte, 2022, Frontiers in Immunology.

Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.

J. Prieto, E. Huarte, J. Lasarte, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination

J. Lasarte, P. Sarobe, Fernando Aranda, 2016, Oncoimmunology.

ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity

P. Sarobe, Diana Llópiz, M. M. Soldevilla, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.